spartan.jpg
Spartan Capital Securities, LLC Serves as Sole Placement Agent in Virpax Pharmaceuticals, Inc.'s $5.0 Million Public Offering
18 nov. 2024 10h23 HE | Spartan Capital Securities, LLC
New York, NY, Nov. 18, 2024 (GLOBE NEWSWIRE) -- Spartan Capital Securities, LLC, a leading investment banking firm, is pleased to announce its role as the sole placement agent in Virpax...
Top Wealth Group Holding Limited Announces Pricing of $10.8 Million Public Offering of Ordinary Shares
11 oct. 2024 09h00 HE | Top Wealth Group Holding Ltd
Hong Kong, Oct. 11, 2024 (GLOBE NEWSWIRE) -- Top Wealth Group Holding Limited (NASDAQ: TWG) (“Top Wealth” or the “Company”), a Hong Kong-based supplier of luxury caviar products, today announced the...
spartan.jpg
Spartan Capital Securities Announces Successful Closing of Siyata Mobile Inc.’s $4.0 Million Public Offering of Common Shares and Pre-Funded Warrants
19 août 2024 11h00 HE | Spartan Capital Securities, LLC
NEW YORK, NY, Aug. 19, 2024 (GLOBE NEWSWIRE) -- Spartan Capital Securities LLC, a premier investment banking firm, is thrilled to announce the successful closing of Siyata Mobile Inc.’s public...
Eureka Acquisition Corp Announces Closing of $50 Million Initial Public Offering
03 juil. 2024 13h31 HE | Eureka Acquisition Corp
Shanghai, July 03, 2024 (GLOBE NEWSWIRE) -- Eureka Acquisition Corp (the “Company”), a blank check company incorporated as a Cayman Islands exempted company today announced the closing of its...
logo.jpg
Beamr Imaging Ltd. Announces Closing of Public Offering and Full Exercise of Underwriter’s Option to Purchase Additional Shares
15 févr. 2024 16h15 HE | Beamr Imaging Ltd.
Herzliya, Israel, Feb. 15, 2024 (GLOBE NEWSWIRE) -- Beamr Imaging Ltd. (Nasdaq: BMR) (“Beamr” or the “Company”), a leader in video optimization technology, today announced the closing of its...
Picture3.jpg
Clearmind Medicine Announces Pricing of US$2.25 Million Public Offering
14 sept. 2023 09h23 HE | Clearmind Medicine Inc.
Tel Aviv, Israel / Vancouver, Canada, Sept. 14, 2023 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (NASDAQ: CMND) (CSE: CMND), (FSE: CWY) (“Clearmind”), a biotech company focused on the discovery and...